Bill Information > HB 1356
Search for another bill or initiative:
HB 1356 - 2023-24
Reducing prescription drug costs by eliminating barriers impeding access to biosimilar medicines.
Sponsors: Reeves, Reed, Lekanoff, Doglio, Donaghy, Springer
Bill Status-at-a-Glance
See Bill History for complete details on the bill
As of Friday, November 22, 2024 12:18 AM
Current Version:
HB 1356
Current Status:
HHC/Wellness
Where is it in the process?
IntroducedIn CommitteeOn FloorCalendarPassedChamberIn the House:In the Senate:
After Passage:Passed LegislatureOn Governor'sDeskGovernor ActedSession Law

Bill Status-at-a-Glance

As of Friday, November 22, 2024 12:18 AM
See Bill History for complete details on the bill
Current Version:
HB 1356
Current Status:
HHC/Wellness
Where is it in the process?
IntroducedIn CommitteeOn FloorCalendarPassedChamber
House:
Senate:
Passed LegislatureOn Governor'sDeskGovernor ActedSession Law
AfterPassage:
Bill History

2023 REGULAR SESSION

IN THE HOUSE

Jan 16
First reading, referred to Health Care & Wellness. (View Original Bill)

2024 REGULAR SESSION

IN THE HOUSE

Jan 8
By resolution, reintroduced and retained in present status.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos